新聞快訊：森西賽智科技與Vizgen公司正式宣布開啟中國區(qū)戰(zhàn)略合作新征程，全方位助力中國空間組學(xué)研究
2024-07-02
北京，2024年7月2日——專注于中國生命科學(xué)工具解決方案的服務(wù)商“森西賽智科技有限公司（SinSage Technology Co. Ltd）”和美國高分辨單細(xì)胞原位空間轉(zhuǎn)錄組學(xué)開創(chuàng)技術(shù)供應(yīng)商“Vizgen，Inc.”在今天高興地宣布：雙方將合作在中國推廣MERSCOPE?及MERSCOPE Ultra?空間基因組學(xué)平臺。
由Vizgen開發(fā)和制造的MERSCOPE系列儀器及相應(yīng)檢測體系采用了突破性的MERFISH技術(shù)（Multiplexed Error Robust Fluorescence In-Situ Hybridization，多重抗錯熒光原位雜交技術(shù)），該核心技術(shù)來自哈佛大學(xué)莊小威院士實驗室，結(jié)合了smFISH（single-molecule Fluorescence In-Situ Hybridization，單分子熒光原位雜交技術(shù)）和單細(xì)胞成像的優(yōu)勢，實現(xiàn)真正意義上的基因可視化的原位單細(xì)胞空間轉(zhuǎn)錄組學(xué)分析。基于超高分辨成像和MERFISH技術(shù)，MERSCOPE?和MERSCOPE Ultra?平臺為單細(xì)胞原位空間組解析提供了強大的研究工具，已經(jīng)助力國內(nèi)外多個研究領(lǐng)域的眾多科學(xué)家獲得高分辨的原位空間組信息和研究成果，正式開啟單細(xì)胞原位空間轉(zhuǎn)錄組學(xué)研究的新紀(jì)元。
作為Vizgen的中國區(qū)戰(zhàn)略合作伙伴成員，森西賽智將和Vizgen團(tuán)隊攜手為中國客戶提供全球先進(jìn)水平原位單細(xì)胞空間轉(zhuǎn)錄組技術(shù)和服務(wù)產(chǎn)品全鏈條平臺綜合性渠道。此次戰(zhàn)略合作將充分整合Vizgen團(tuán)隊的技術(shù)專長、產(chǎn)品和應(yīng)用積累，協(xié)同森西賽智在國內(nèi)生命科學(xué)領(lǐng)域完善的服務(wù)網(wǎng)絡(luò)，為廣大中國科學(xué)家客戶提供卓越的單細(xì)胞高分辨原位空間組服務(wù)產(chǎn)品完整解決方案。
Vizgen全球總裁兼首席執(zhí)行官Terry Lo表示：“Vizgen很高興能與森西賽智這樣富有遠(yuǎn)見的合作伙伴一起拓展其在中國的業(yè)務(wù)和服務(wù)。此次合作將大幅提升MERSCOPE?和MERSCOPE Ultra?平臺在中國各科研領(lǐng)域的覆蓋面和服務(wù)能力。”
森西賽智的總經(jīng)理王巖先生表示：“我們對與Vizgen的合作充滿信心，MERFISH技術(shù)是下一代轉(zhuǎn)錄組學(xué)技術(shù)，已經(jīng)在單細(xì)胞空間組學(xué)研究方面取得了非常多的研究成果，必將幫助中國的生命科學(xué)研究在腫瘤生物學(xué)、免疫學(xué)、神經(jīng)科學(xué)、生殖醫(yī)學(xué)、發(fā)育生物學(xué)、植物學(xué)和農(nóng)業(yè)等領(lǐng)域取得突破，有助于加速基礎(chǔ)研究的發(fā)展和藥物開發(fā)的進(jìn)程。我們的合作將助力中國的空間轉(zhuǎn)錄組學(xué)研究技術(shù)不斷發(fā)展！”
兩家公司都期待與中國的共同客戶建立長期、緊密的合作。
關(guān)于Vizgen?
Vizgen致力于開拓下一代基因組學(xué)，提供展示原位單細(xì)胞空間基因組學(xué)廣闊潛能的工具。該公司在空間基因組學(xué)領(lǐng)域建立了基準(zhǔn)，并持續(xù)推動行業(yè)創(chuàng)新，提供最高的靈敏度、出色的特異性以及高度精確的細(xì)胞分割。這些工具使研究人員能夠通過空間背景對調(diào)控人類健康和疾病的生物系統(tǒng)不斷獲得新的見解。Vizgen的MERSCOPE?及MERSCOPE Ultra?平臺集成超高分辨成像與MERFISH技術(shù)自動化，可在亞細(xì)胞分辨率下實現(xiàn)大規(guī)模多重、基因組規(guī)模的核酸與蛋白分子成像，具有高精度和無與倫比的檢測效率。MERSCOPE?為腫瘤學(xué)、免疫學(xué)、神經(jīng)科學(xué)、傳染病、發(fā)育生物學(xué)、植物學(xué)、農(nóng)業(yè)、細(xì)胞和基因治療等領(lǐng)域廣泛的基于全組織的基礎(chǔ)研究和轉(zhuǎn)化醫(yī)學(xué)提供了變革性的見解，是加速藥物發(fā)現(xiàn)和開發(fā)的重要工具。截至2024年3月，應(yīng)用Vizgen技術(shù)發(fā)表的高質(zhì)量研究項目文獻(xiàn)已有200多篇，其中超過50篇影響因子大于50分。更多信息，請參考網(wǎng)站：www.vizgen.com 及微信公眾號：Vizgen_China。
關(guān)于森西賽智
“森西賽智科技有限公司”（北京/上海/廣州/成都）擁有超過20年的生命科學(xué)和生物技術(shù)領(lǐng)域的自主研發(fā)和國際品牌代理經(jīng)驗，專注于國內(nèi)整合和推進(jìn)全球產(chǎn)品進(jìn)入中國的研發(fā)市場，產(chǎn)品線覆蓋分子、蛋白、細(xì)胞、組織、小動物、生物工藝和自動化等領(lǐng)域。森西賽智在全國各主要城市都有銷售或售后服務(wù)網(wǎng)點，相關(guān)工作人員均接受原廠培訓(xùn)，具有雄厚的技術(shù)支持基礎(chǔ)，可以為客戶提供專業(yè)周到的服務(wù)。自成立以來，森西賽智已為5300+客戶提供優(yōu)質(zhì)的產(chǎn)品和服務(wù)。在森西賽智，我們堅信“科技為先（Science First)”!
聯(lián)系方式：
Vizgen
Email: [email protected];[email protected]
電話: +001-833-222-8206
網(wǎng)站: www.vizgen.com
森西賽智
Email: [email protected]
電話: +86-10-61666616
網(wǎng)站: www.sinsage.com.cn
News Flash: SinSage Technology Becomes a Strategic Partner for Vizgen in China
Beijing, July 2, 2024 – SinSage Technology Co. Ltd., a provider of life science tool solutions in China, and Vizgen, Inc. a US-based pioneer in high-resolution single-cell spatial transcriptomics technology, are delighted to announce their partnership to promote the MERSCOPE? and MERSCOPE Ultra? spatial genomics platforms in China.
Developed and manufactured by Vizgen, the MERSCOPE series of instruments and associated reagents and consumables utilize ground-breaking MERFISH technology (Multiplexed Error Robust Fluorescence In-Situ Hybridization), a core technology from the lab of Professor Xiaowei Zhuang at Harvard University. This technology combines the advantages of smFISH (single-molecule Fluorescence In-Situ Hybridization) and single-cell imaging to achieve true single-cell spatial transcriptomics analysis. The MERSCOPE? and MERSCOPE Ultra? Platforms, based on ultra-high-resolution imaging and MERFISH technology, provide powerful research tools, ushering in a new era for transcriptomics research.
As a strategic partner of Vizgen in China, SinSage Technology will collaborate with the Vizgen team to provide a comprehensive channel for high-level single-cell spatial transcriptomics technology and services to its customers. This strategic partnership will fully integrate Vizgen's technical expertise, products, and applications with SinSage Technology's extensive service network in the life sciences field, providing Chinese scientists with excellent single-cell high-resolution spatial genomics solutions.
Vizgen CEO Terry Lo stated, “Vizgen is thrilled to expand its reach into China with a visionary partner like SinSage Technology. This partnership will increase access and adoption of the MERSCOPE platform for the research community throughout China.”
Mr. Wang Yan, General Manager of SinSage Technology, said, “We are confident in our partnership with Vizgen. MERFISH technology is the next generation of transcriptomics technology and will help Chinese life sciences research achieve breakthroughs in oncology, immunology, neuroscience, reproductive medicine, developmental biology, botany, agriculture and more. Our collaboration will continuously advance spatial transcriptomics research in China!”
Both companies look forward to establishing long-term, close cooperation with their shared customers in China.
About Vizgen?
Vizgen is committed to pioneering the next generation of genomics, providing tools that unveil the vast potential of in situ single-cell spatial genomics. The company has set benchmarks in the field of spatial genomics and continues to drive industry innovation, offering the highest sensitivity, outstanding specificity, and highly precise cell segmentation. These tools enable researchers to continuously gain new insights into the biological systems that regulate human health and disease through a spatial context. Vizgen’s MERSCOPE? and MERSCOPE Ultra? platforms integrate ultra-high-resolution imaging with automated MERFISH technology, enabling large-scale multiplex, genome-scale nucleic acid and protein molecule imaging at subcellular resolution with high precision and unparalleled detection efficiency. MERSCOPE? provides transformative insights for a wide range of fields including oncology, immunology, neuroscience, infectious diseases, developmental biology, botany, agriculture, cell and gene therapy, and is a crucial tool in accelerating drug discovery and development. As of March 2024, over 200 high-quality research papers applying Vizgen technology have been published, with more than 50 having an impact factor greater than 50. For more information, please visit: www.vizgen.com and WeChat account: Vizgen_China.
About SinSage Technology
SinSage Technology Co., Ltd., with over 20 years of experience in autonomous research and development and international brand representation in the life sciences and biotechnology sectors, is dedicated to integrating and advancing global products into China’s research and development market. Its product line spans molecular, protein, cellular, tissue, small animal, bioprocess, and automation fields. SinSage has sales or after-sales service outlets in major cities across China, and its staff, trained by the original manufacturers, have a solid technical support foundation and can provide professional and thorough service. Since its establishment, SinSage has served over 5,300 customers with high-quality products and services. At SinSage, we firmly believe in “Science First”!
Contact Information:
Vizgen
Email: [email protected];[email protected]
Phone: +001-833-222-8206
Website: www.vizgen.com
SinSage Technology
Email: [email protected]
Phone: +86-10-61666616
Website: www.sinsage.com.cn